William C. Campbell
Parasitologist, Fellow 1990 – 2010, RISE Associate since 2010, formerly Senior Director, Basic Parasitology, Merck & Company, Inc.
Ph.D., University of Wisconsin, 1957
Research Interests: Parasitology, chemotherapy of parasitic infections
Contact: firstname.lastname@example.org, 973-408-3096
Neal C. Connors
Microbiologist, RISE Associate since 2012. Formerly Senior Investigator, Bioprocess R&D, Merck Research Labs. Currently President of Phoenix BioConsulting, LLC and CTO of Kalion, Inc
Ph.D., Ohio State University, 1991.
Research Interests: Microbial fermentation, bioprocess development, therapeutic natural products, renewable fuels and chemicals.
Contact: email@example.com, 973-408-3794, HSC 318
Molecular Biologist, Fellow since 2011, formerly Research Fellow of Oncology and Virology drug discovery research at Schering-Plough Co.
Ph.D., University of Calcutta, India, 1977
Research Interests: Drug discovery in Oncology. Studying tumor suppressor genes, oncogenes and their functional modulation by small molecules for development of cancer therapeutics. Antiviral discovery research.
Contact: firstname.lastname@example.org 973-408-3078, HSC 325
Arnold L. Demain
Microbial Biochemist, Fellow since 2001, formerly Professor of Industrial Microbiology in the Biology Department, MIT.
Previously Founder and Head of Department of Fermentation Microbiology at Merck & Co., Inc.
Ph.D., University of California, Berkeley and Davis, 1954
Research Interests: Regulation of microbial fermentations, biotransformations, natural products
Contact: email@example.com, 973-408-3937, HSC 330
Ronald J. Doll
Organic Chemist, Fellow since 2010, formerly Director of Chemical Research, Infectious Diseases and Tumor Biology, Schering-Plough Research Institute and Merck Research Laboratories.
Ph.D., Duke University, 1975.
Research Interests: Synthetic organic chemistry, medicinal chemistry, synthetic methods and preparing compounds with interesting biological, chemical and physical properties.
Contact: firstname.lastname@example.org, 973-408-3168, HSC 332
John R Eickmeyer
Physicist, Systems Engineer, Fellow since 2012, formerly Distinguished Member of Technical Staff, General Dynamics Advanced Information Systems and Chief Engineer, Bell Laboratories.
Ph.D. Cornell University 1976
Research Interests: Optics; Optical Communications; Fundamental Problems in Quantum Mechanics including coherence, decoherence and the transition to classical physics.
Contact: email@example.com 973-408-4983, HSC 325
C. Anderson Evans
Spectroscopist, RISE Associate since 2012, formerly member of Small Molecule Structure Elucidation Group at Schering-Plough and Merck.
B.S. Chem at Georgia Tech, Ph. D. Organic Chemistry, University of Georgia, 1974
Research Interests: Organic structure determination, small molecule binding
to micelles, NMR pulse programming, NMR density matrix calculations
Contact: firstname.lastname@example.org 973-408-4981, HSC 318
Organic Chemist, Fellow since 2007, formerly Vice President of Drug Discovery, Cetek Corporation, previously, Senior Director of New Lead Discovery, Schering Plough Research Institute, and Research Fellow, Natural Product Chemistry, Merck & Co., Inc.
Ph.D., Columbia University, 1975
Research Interests: Drug discovery, natural products, high throughput screening, medicinal chemistry
Contact: email@example.com, 973-408-3904, HSC 331
Jon R. Kettenring
Statistician, Director of RISE since 2008, Fellow since 2004, formerly Executive Director, Bellcore and Telcordia Technologies.
Ph.D., University of North Carolina, 1969
Research Interests: Multivariate methods, robust methods, outlier detection, cluster analysis, data analysis
Contact: firstname.lastname@example.org, 973-408-3829, HSC 322
Charles A. Lunn
Biochemist, Fellow since 2013, formerly Research Fellow, In Vitro Pharmacology/Antimicrobial Antifungal, New Lead Discovery and Immunology at Schering-Plough Research Institute and Merck Research Laboratories.
PhD, Johns Hopkins University, 1983.
Research Interests: Cannabinoid biology, immune modulation, cell migration and cancer metastasis, phenotype-based drug discovery “Cell migration is required phenotype for all autoimmune reactions and for cancer metastasis.
Contact: email@example.com, 973-408-3597, HSC 333
James M. Miller
Chemist, Fellow since 1997 2013, RISE Associate since 2013, formerly Professor of Chemistry, Drew University.
Ph.D., Purdue University, 1960
Research Interests: Analytical chemistry, chromatography, capillary electrophoresis
Contact: firstname.lastname@example.org, 973-408-3369 HSC 333
Cell Biologist, RISE Visiting Scientist since 2014; formerly, Lead Research Investigator in Discovery Research at Sanofi Pharmaceuticals.
Ph.D. – 1981, at the Inst. of Cancer Research (University of London), U.K.; Immunology.
Research Interests: Cell Biology; particularly quantitative cell imaging, with application to restoring normal cell functions or stimulating self-regenerative processes as therapies for human disease.
Contact: email@example.com, 973-408-3445, HSC 329
Biochemist, Fellow since 1997, formerly Research Fellow, CIBA-Geigy (Novartis).
Ph.D., New York University Medical Center, 1957
Research Interests: Enzymology, regulation of metabolism, nitric oxide, Alzheimer’s disease, diabetes
Contact: firstname.lastname@example.org, 973-408-3567, HSC 329